Clinical Trials Browser

Phase 2/3 × empagliflozin × Clear all

NCT06140108 2025-05-14

Empagliflozin vs Metformin on Metabolic Dysfunction in Polycystic Ovary Syndrome With or Without Comorbidity or Multimorbidity

Phase 2/3 Completed

Polycystic Ovary Syndrome, Weight Gain

NCT06103279 2023-10-26

Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin

Phase 2/3 Unknown

Neoplasms

NCT03008551 2019-07-15

Empagliflozin vs Metformin in PCOS

Phase 2/3 Completed

Polycystic Ovary Syndrome